Studies of the expression of the Wiskott-Aldrich syndrome protein
- PMID: 8647957
- PMCID: PMC507350
- DOI: 10.1172/JCI118712
Studies of the expression of the Wiskott-Aldrich syndrome protein
Abstract
The Wiskott-Aldrich syndrome (WAS) is an X-linked disorder characterized by thrombocytopenia, eczema, disorders in cell-mediated and humoral immunity, and a proclivity to lymphoproliferative disease. The gene responsible encodes a 53-kD proline-rich protein of unknown function (WASP). We produced a FLAG-WASP fusion protein that was used to immunize mice and produce mAbs against WASP. Using monoclonal anti-WASP in Western immunoblots, we have determined that WASP is present in the cytoplasmic but not nuclear fraction of normal human peripheral blood mononuclear cells, in normal human platelets, in T lymphocytes, non-T lymphocytes, and monocytes. The protein is produced in the B cell immunoblastic cell line DS-1, in normal EBV-transformed B cell lines, and in HEL92.1.7, but is barely detectable in MOLT-4 and not detectable in K562. WASP was present in two of four EBV-transformed cell lines from WAS patients. Splenic tissue immunostaining was performed in two patients, and the results correlated with the results of the Western blots. Sequence analysis of WASP cDNA from two patients who produce WASP show mutations causing amino acid substitutions. These studies establish a foundation for further studies aimed at understanding the function of WASP.
Comment in
-
The enigma of the Wiskott-Aldrich syndrome begins to unravel.J Clin Invest. 1996 Jun 1;97(11):2407. doi: 10.1172/JCI118686. J Clin Invest. 1996. PMID: 8647931 Free PMC article. No abstract available.
Similar articles
-
Defective actin polymerization in EBV-transformed B-cell lines from patients with the Wiskott-Aldrich syndrome.J Pathol. 1998 May;185(1):99-107. doi: 10.1002/(SICI)1096-9896(199805)185:1<99::AID-PATH48>3.0.CO;2-L. J Pathol. 1998. PMID: 9713366
-
Mutations that cause the Wiskott-Aldrich syndrome impair the interaction of Wiskott-Aldrich syndrome protein (WASP) with WASP interacting protein.J Immunol. 1999 Apr 15;162(8):5019-24. J Immunol. 1999. PMID: 10202051
-
Variable expression of WASP in B cell lines of Wiskott-Aldrich syndrome patients.J Immunol. 1997 May 1;158(9):4021-5. J Immunol. 1997. PMID: 9126958
-
Wiskott-Aldrich syndrome (role of WASP).J Med Dent Sci. 2001 Mar;48(1):1-6. J Med Dent Sci. 2001. PMID: 12160237 Review.
-
Wiskott-Aldrich syndrome.Curr Opin Hematol. 2008 Jan;15(1):30-6. doi: 10.1097/MOH.0b013e3282f30448. Curr Opin Hematol. 2008. PMID: 18043243 Review.
Cited by
-
Antigen receptor-induced activation and cytoskeletal rearrangement are impaired in Wiskott-Aldrich syndrome protein-deficient lymphocytes.J Exp Med. 1999 Nov 1;190(9):1329-42. doi: 10.1084/jem.190.9.1329. J Exp Med. 1999. PMID: 10544204 Free PMC article.
-
Second-site mutation in the Wiskott-Aldrich syndrome (WAS) protein gene causes somatic mosaicism in two WAS siblings.J Clin Invest. 2003 May;111(9):1389-97. doi: 10.1172/JCI15485. J Clin Invest. 2003. PMID: 12727931 Free PMC article.
-
Effects of eltrombopag on platelet count and platelet activation in Wiskott-Aldrich syndrome/X-linked thrombocytopenia.Blood. 2015 Sep 10;126(11):1367-78. doi: 10.1182/blood-2014-09-602573. Epub 2015 Jul 29. Blood. 2015. PMID: 26224646 Free PMC article. Clinical Trial.
-
Generation of a lentiviral vector producer cell clone for human Wiskott-Aldrich syndrome gene therapy.Mol Ther Methods Clin Dev. 2015 Jan 21;2:14063. doi: 10.1038/mtm.2014.63. eCollection 2015. Mol Ther Methods Clin Dev. 2015. PMID: 26052531 Free PMC article.
-
Analysis of T-cell repertoire diversity in Wiskott-Aldrich syndrome.Blood. 2005 Dec 1;106(12):3895-7. doi: 10.1182/blood-2005-06-2336. Epub 2005 Aug 9. Blood. 2005. PMID: 16091449 Free PMC article.